Access cutting-edge generalized epilepsy treatment through this clinical trial at a research site in Lancaster. Study-provided care at no cost to qualified participants.
Access generalized epilepsy specialists in Lancaster at no cost
This study follows strict safety protocols and ethical guidelines
All study-related generalized epilepsy treatment provided free
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of idiopathic generalized epilepsy with generalized tonic-clonic seizures and includes an additional open-label extension (OLE) phase.
Sponsor: Biohaven Therapeutics Ltd.
Check if you qualify for this generalized epilepsy clinical trial in Lancaster, CA
If you're searching for generalized epilepsy treatment options in Lancaster, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lancaster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced generalized epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.